Rare diseases
Investigational molecules
Locations
Baldingerstrasse, 35043 Marburg, Germany
Philipps-Universitaet Marburg in Marburg, Germany specialises in clinical trials of conditions such as Acute myeloid leukaemia, Conjunctivitis allergic, Oesophageal adenocarcinoma, Partial seizures, and other specialisations. This site conducts important research.
The clinic focuses on eye diseases, investigating conditions such as macular edema due to central retinal vein occlusion and moderate-to-severe thyroid eye disease, with the goal of refining treatment protocols and reducing injection burden.
Collaboration with Philipps-Universitaet Marburg enables multidisciplinary expertise and patient‑centered outcomes.
Research in hematologic and lymphatic diseases targets acute myeloid leukemia, early‑stage unfavorable classical Hodgkin lymphoma, large B‑cell lymphoma, and MSI‑high colorectal cancer, aiming to improve survival through innovative cellular and immunotherapies.
With 50 investigators, the site advances precision oncology across multiple cancer types.
The department studies immune system diseases such as thyroid eye disease, employing novel biologics like satralizumab to assess efficacy and safety while seeking to lessen disease‑related disability.
As an educational institution, the site integrates clinical insight with academic research.
Investigations into prostate cancer focus on metastatic hormone‑sensitive disease, comparing docetaxel dosing schedules and combining chemotherapy with darolutamide plus androgen deprivation therapy to enhance progression‑free survival.
Commercial partnerships support the development of optimized therapeutic regimens.
The site addresses neoplasms including metastatic colorectal cancer, advanced HER2‑negative breast cancer, and melanoma, evaluating checkpoint inhibitors and combination regimens to extend overall survival and understand resistance patterns.
A total of 11 clinical trials contribute to a comprehensive oncology portfolio.
Efforts in nervous system diseases concentrate on refractory status epilepticus, testing adjunctive IV ganaxolone added to standard antiepileptic drugs to improve seizure control and patient safety.
The program aims to deliver faster, more effective interventions for life‑threatening seizures.
Clinical trials currently enrolling participants at this site.
A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
GermanyA study testing duvakitug for patients with moderately to severely active ulcerative colitis
GermanyA Study of Darovasertib Before Surgery or Radiation Therapy for Patients with Early-Stage Uveal Melanoma That Has Not Spread
GermanyA Study of Ivonescimab Combined with Fluorouracil, Folinic Acid, and Oxaliplatin Compared to Bevacizumab for Patients with Metastatic Colorectal Cancer
GermanyStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
GermanyStudy on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen
GermanyStudy on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions
GermanyA Phase 3 Study of Engasertib to Evaluate Safety and Effectiveness in Adults with Moderate to Severe Hereditary Hemorrhagic Telangiectasia
GermanyDurvalumab plus drug combination as total neoadjuvant therapy for patients with resectable gastroesophageal adenocarcinoma
GermanyStudy of AZD0901 (sonesitatug vedotin) with capecitabine ± rilvegostomig in adults with advanced stomach or esophageal cancer (Claudin‑18.2‑positive, HER2‑negative)
GermanyStudy of mirikizumab versus azathioprine in newly diagnosed moderate-to-severe Crohn’s disease patients
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
